Clin2
NCT04627870Possibly a fitRecruiting

Drug-coated balloon treatment for recurrent brain stent narrowing

Intracranial AtherosclerosisStroke

Part of Brain & nervous system, Heart & circulation clinical trials.

This pilot study tests a catheter treatment called a drug-coated balloon to treat repeat narrowing inside a previously placed brain stent. It may help people whose stent has narrowed again and is causing reduced blood flow or stroke/TIA symptoms despite best medical therapy.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
20 people
Ages
18 years to 80 years
Study type
Interventional

Who can take part

  • Your age is 18 to 80 years old.
  • You have one confirmed repeat narrowing inside a brain stent (in-stent restenosis) in specific brain arteries (internal carotid, middle cerebral, basilar, or vertebral).
  • Your symptoms match one of these: prior stroke or TIA from this problem despite medication, or no symptoms but significant reduced blood flow on brain scan (or poor collateral flow on angiogram).
  • The narrowed vessel size is between 2.0 and 4.5 mm, and you have only one ISR lesion in the brain.
  • Your baseline disability score is mild (mRS 0–2), and you can take the study’s dual anti-platelet medicines (blood thinners) and tolerate the procedure’s anesthesia/contrast drugs.
  • You have NOT had recent stroke (within 2 weeks), recent brain bleeding (within 30 days), recent worsening stroke symptoms (within 24 hours), or a clot in the target vessel; and you have no other brain lesions that also need catheter treatment.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT04948749Recruiting
Stenting plus medication to prevent stroke from narrowed brain arteries

This trial tests whether placing a stent in a severely narrowed brain artery, along with aggressive medication, can prevent another stroke better than medication alone. It is for people who had a mild stroke within the last 30 days due to a 70-99% blockage in a major brain artery.

Beijing, Beijing Municipality
NCT06614972Not yet recruiting
Balloon stent study for narrowed brain arteries

This study tests a special balloon-expandable stent to treat narrowed arteries in the brain that have not improved with medication. It aims to help people who have had strokes or TIAs despite taking medicines for risk factors like high blood pressure or diabetes.

NCT05757505Recruiting
Intracranial stent for narrowed brain arteries after symptoms

This trial studies whether an intracranial stent (a small mesh tube placed inside the brain artery) improves outcomes and safety for people with severe, symptomatic narrowing of brain arteries. It may help if symptoms continue despite antiplatelet medicine or if blood flow to the brain is poor.

Luoyang, Henan
NCT03729817Not yet recruiting
Angioplasty for narrowed brain arteries after a recent stroke

This study tests a safer, lower-intensity balloon procedure to improve blood flow in people whose brain arteries are narrowed and who recently had a stroke. It aims to reduce the chance of another stroke by restoring flow while minimizing procedure-related risks.

Cleveland, Ohio
NCT06472336Recruiting
Stenting for severe stroke caused by plaque buildup

This trial tests whether placing a stent (a tiny tube) in the blocked artery in the brain can improve blood flow and help people recover from a severe stroke, especially when standard clot removal has not worked.

Basel, Canton of Basel-City
NCT06683118Enrolling by invitation
Drug-coated balloon for blocked brain arteries

This trial tests whether a drug-coated balloon can safely open a severely blocked brain artery (at least 70% blocked) that remains symptomatic despite medication. It is designed for people who have not had a recent stroke or other major health problems.

Beijing, Beijing Municipality

Hear when a new Intracranial Atherosclerosis trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.